Advances of radiation oncology in China
文献类型：期刊论文
| 刊名 | CHINESE MEDICAL JOURNAL
 |
| 出版日期 | 2009 |
| 卷号 | 122 |
| 关键词 | RESIDUAL PRIMARY LESION CELL LUNG-CANCER NASOPHARYNGEAL CARCINOMA RADIOTHERAPY MANAGEMENT TRIAL advance radiation oncology China |
| ISSN号 | 0366-6999 |
| 其他题名 | Advances of radiation oncology in China |
| 英文摘要 | Radiation therapy is one of the main treatment modalities used in cancer management. It is the primary curative modality for about 30% of patients with cancer, and more than half of all cancer patients received radiation therapy sometime during the course of their disease. It is estimated that 70% of the patients with cancer required radiation therapy in China. |
| 语种 | 英语 |
| CSCD记录号 | CSCD:3681755 |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/63476]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 推荐引用方式 GB/T 7714 | . Advances of radiation oncology in China[J]. CHINESE MEDICAL JOURNAL,2009,122. |
| APA | (2009).Advances of radiation oncology in China.CHINESE MEDICAL JOURNAL,122. |
| MLA | "Advances of radiation oncology in China".CHINESE MEDICAL JOURNAL 122(2009). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。